Literature DB >> 27185291

Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator.

Amandeep K Gakhal1, Timothy J Jensen2, Zoltan Bozoky3,4, Ariel Roldan5, Gergely L Lukacs5, Julie Forman-Kay3,4, John R Riordan2, Sachdev S Sidhu1.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel in the apical surface of epithelial cells in the airway and gastrointestinal tract, and mutation of CFTR is the underlying cause of cystic fibrosis. However, the precise molecular details of the structure and function of CFTR in native and disease states remains elusive and cystic fibrosis researchers are hindered by a lack of high specificity, high affinity binding reagents for use in structural and biological studies. Here, we describe a panel of synthetic antigen-binding fragments (Fabs) isolated from a phage-displayed library that are specific for intracellular domains of CFTR that include the nucleotide-binding domains (NBD1 and NBD2), the R-region, and the regulatory insertion loop of NBD1. Binding assays performed under conditions that promote the native fold of the protein demonstrated that all Fabs recognized full-length CFTR. However, only the NBD1-specific Fab recognized denatured CFTR by western blot, suggesting a conformational epitope requirement for the other Fabs. Surface plasmon resonance experiments showed that the R-region Fab binds with high affinity to both the phosphorylated and unphosphorylated R-region. In addition, NMR analysis of bound versus unbound R-region revealed a distinct conformational effect upon Fab binding. We further defined residues involved with antibody recognition using an overlapping peptide array. In summary, we describe methodology complementary to previous hybridoma-based efforts to develop antibody reagents to CFTR, and introduce a synthetic antibody panel to aid structural and biological studies.

Entities:  

Keywords:  Cystic fibrosis conductance regulator; membrane protein; phage display; protein engineering; synthetic antibody

Mesh:

Substances:

Year:  2016        PMID: 27185291      PMCID: PMC4968092          DOI: 10.1080/19420862.2016.1186320

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  36 in total

1.  Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter.

Authors:  JungMin Kim; Shenping Wu; Thomas M Tomasiak; Claudia Mergel; Michael B Winter; Sebastian B Stiller; Yaneth Robles-Colmanares; Robert M Stroud; Robert Tampé; Charles S Craik; Yifan Cheng
Journal:  Nature       Date:  2014-11-02       Impact factor: 49.962

2.  Domain interdependence in the biosynthetic assembly of CFTR.

Authors:  Liying Cui; Luba Aleksandrov; Xiu-Bao Chang; Yue-Xian Hou; Lihua He; Tamas Hegedus; Martina Gentzsch; Andrei Aleksandrov; William E Balch; John R Riordan
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

3.  F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.

Authors:  Tamás Hegedus; Andrei Aleksandrov; Liying Cui; Martina Gentzsch; Xiu-Bao Chang; John R Riordan
Journal:  Biochim Biophys Acta       Date:  2006-03-31

4.  High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.

Authors:  Frederic A Fellouse; Kaori Esaki; Sara Birtalan; Demetrios Raptis; Vincenzo J Cancasci; Akiko Koide; Parkash Jhurani; Mark Vasser; Christian Wiesmann; Anthony A Kossiakoff; Shohei Koide; Sachdev S Sidhu
Journal:  J Mol Biol       Date:  2007-08-19       Impact factor: 5.469

5.  Crystal structure of full-length KcsA in its closed conformation.

Authors:  Serdar Uysal; Valeria Vásquez; Valentina Tereshko; Kaori Esaki; Frederic A Fellouse; Sachdev S Sidhu; Shohei Koide; Eduardo Perozo; Anthony Kossiakoff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

6.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

7.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.

Authors:  S H Cheng; D P Rich; J Marshall; R J Gregory; M J Welsh; A E Smith
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

9.  Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance.

Authors:  N Kartner; J W Hanrahan; T J Jensen; A L Naismith; S Z Sun; C A Ackerley; E F Reyes; L C Tsui; J M Rommens; C E Bear
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

View more
  2 in total

1.  A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties.

Authors:  Zvezdan Pavlovic; Jarrett J Adams; Levi L Blazer; Amandeep K Gakhal; Nick Jarvik; Zachary Steinhart; Mélanie Robitaille; Keith Mascall; James Pan; Stephane Angers; Jason Moffat; Sachdev S Sidhu
Journal:  MAbs       Date:  2018-09-25       Impact factor: 5.857

Review 2.  Recent Strategic Advances in CFTR Drug Discovery: An Overview.

Authors:  Marco Rusnati; Pasqualina D'Ursi; Nicoletta Pedemonte; Chiara Urbinati; Robert C Ford; Elena Cichero; Matteo Uggeri; Alessandro Orro; Paola Fossa
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.